|
KEYNOTE-224: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis; Pfizer |
Research Funding - Pfizer (Inst) |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb |
|
|
|
Consulting or Advisory Role - Bayer; Eisai |
|
|
Honoraria - Bayer; Bristol-Myers Squibb; Celgene; Nucana |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Nucana |
Research Funding - Bayer; Nucana |
|
|
Consulting or Advisory Role - Bayer; Ipsen; Sirtex Medical |
Speakers' Bureau - Bayer; Sirtex Medical |
Research Funding - Bayer; Ipsen |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; Gilead Sciences |
Consulting or Advisory Role - Eisai; Transgene |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb |
|
|
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi |
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche |
Research Funding - Novartis |
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche |
|
|
Honoraria - Pfizer; Pfizer (I) |
Consulting or Advisory Role - Baxalta; Blueprint Medicines; Eisai (I); Ipsen (I); Novartis |
Travel, Accommodations, Expenses - Bayer; ipsen |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - AstraZeneca/MedImmune; MSD Oncology; Novartis |
Research Funding - Novartis; Sirtex Medical |
|
|
|
Consulting or Advisory Role - Lilly; Merck |
Research Funding - AstraZeneca |
|
|
Honoraria - Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; MSD |
Consulting or Advisory Role - Bayer; Eisai |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; Novartis; Ono Pharmaceutical; ONXEO |
Speakers' Bureau - Novartis |
Research Funding - Sanofi |
|
|
Honoraria - Ajinomoto; Bayer; Eisai; MSD |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; MSD; Taiho Pharmaceutical |
Research Funding - Abbvie; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda |